Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 51,500 shares at $41.07 ($2.1M) on 2026-04-14, disclosed to the SEC on 2026-04-15.
Scheduled sale ($2.1M) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.07 | 37,500 | $1.5M | 72.4% |
| 2 | $41.93 | 7,215 | $303K | 14.2% |
| 3 | $41.62 | 5,226 | $218K | 10.2% |
| 4 | $42.53 | 1,559 | $66K | 3.1% |
| Total | $41.29 avg | 51,500 | $2.1M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |
| TVTX | SELL | 2026-02-19 | $557K | — | Filing → |